- Global biotech company I-Mab (NASDAQ:IMAB) said that Board of Directors appointed Mr. Wei Fu as the chairman of the Board of Directors.
- He succeeds Dr. Pamela M. Klein, who steps down from I-Mab’s (IMAB) Board of Directors and the interim chairperson position.
- In addition, Mr. Raj Kannan intends to leave his role as CEO and as a member of the company’s Board of Directors, effective July 15, 2024.
- Mr. Kannan will stay as an advisor of the company until July 31, 2024, to assist with the transition.
- Dr. Sean Xi-Yong Fu has assumed the role of interim CEO and a member of the Board of Directors, effective July 15, 2024.
2024-07-15